Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: mitral valve endocarditis major surgical or invasive procedure: mitral valve replacement(31-mm mosaic mitral valve bioprosthesis),tricuspid valvuloplasty(28-mm mc3 valvuloplasty ring),closure of patent foramen ovale. history of present illness: this 54 year old female was seen originally in for mitral valve endocarditis (strep oralis). she was treated with intravenous antibiotics, however, was readmitted in congestive heart failure. at that time, she was diuresed and surgical planning began. she completed her antibiotics (penicillin) on and her picc line was removed. she presents today for surgical management of her mitral and tricuspid valve disease. past medical history: iron deficiency anemia s/p cesarean section endocarditis pulmonary hypertension h/o congestive heart failure h/o cervical osteomyelitis h/o septic arthritis h/o splenic and renal spetic emboli s/p vein stripping surgery social history: remote tobacco as a teenager. denies etoh. employed at target. family history: non-contributory physical exam: admission: t 96.7 bp 112/75 p 61 r12 wt 160lbs gen: well appearing, nad heent:anicteric, op clear neck:supple, no lad lungs: ctab, no crackles cv: rrr nl s1 and s2 iii/vi holosystolic murmur abd:soft, nt, nd, +bs ext: no edema neuro:nonfocal pertinent results: echo pre-bypass: the left atrium is dilated. no spontaneous echo contrast or thrombus is seen in the body of the left atrium/left atrial appendage or the body of the right atrium/right atrial appendage. left ventricular wall thickness, cavity size and regional/global systolic function are normal (lvef >55%). right ventricular chamber size and free wall motion are normal. the aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. the mitral valve is abnormal. there is a torn anterior leaflet at the a2 and all regurgitation is seen through this tear. there is a moderate-sized vegetation on the mitral valve. severe (4+) mitral regurgitation is seen. the tricuspid valve does not appear to have any vegetations and there is moderate to severe tricuspid regurgitation is seen with dilated ivc (28mm) and no change in diameter with respiration seen. there is flow reversal in the hepatic vein as well. there is severe pulmonary artery systolic hypertension. there is a small pericardial effusion. dr. was notified in person of the results on at 8am. 06:52am blood wbc-5.2 rbc-2.88* hgb-8.6* hct-26.3* mcv-92 mch-29.9 mchc-32.7 rdw-17.7* plt ct-155 06:52am blood glucose-94 urean-25* creat-0.9 na-134 k-4.0 cl-97 hco3-26 angap-15 brief hospital course: ms. was admitted to the on for surgical management of her valve disease. she was taken directly to the operating room where she underwent mitral valve replacement using a porcine prosthesis, tricuspid valve repair, pfo clsoure and ligation of the left atrial appendage. please see operative note for details. postoperatively she was taken to the intensive care unit for monitoring. she weaned from bypass on epinephrine, vasopressin, neo synephrine and propofol. she later awoke neurologically intact and was extubated. pressors were weaned off and she remained hemodynamically stable. aspirin, lipitor and beta blockade were resumed. on postoperative day one, she was transferred to the step down unit for for further recovery. she was gently diuresed towards her preoperative weight. the physical therapy service was consulted for assistance with her postoperative strength and mobility. benadryl was given for a rash she had prior to admission with good relief. operative cultures were negative for aerobic growth and perioperative cephalosporins were discontinued on the fourth postoperative day. she continued to make steady progress and was discharged home on pod 4. arrangements for follow up, post discharge instructions and medications were discussed with the patient prior to discharge. medications on admission: atorvastatin 20', lopressor 25", lasix 40', kcl, pcn g completed discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 2. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day) for 2 weeks. disp:*28 tablet(s)* refills:*0* 3. atorvastatin 20 mg tablet sig: one (1) tablet po daily (daily). 4. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 5. acetaminophen 325 mg tablet sig: two (2) tablet po q4h (every 4 hours) as needed. 6. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain for 2 weeks. disp:*50 tablet(s)* refills:*0* 7. thiamine hcl 100 mg tablet sig: one (1) tablet po daily (daily). 8. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 9. furosemide 40 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 10. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day. disp:*30 tab sust.rel. particle/crystal(s)* refills:*2* discharge disposition: home with service facility: all care vna of greater discharge diagnosis: s/p mitral valve replacement, tricuspid annuloplasty, closure of patent foramen ovale, ligation of left atrial appendage mitral valve endocarditis h/0 congestive heart failure pulmonary hypertension iron deficiency anemia patent foramen ovale h/o septic arthritis h/o splenic septic emboli h/o renal septic emboli discharge condition: good discharge instructions: report any redness of, or drainage from incisions report any fever greater then 100.5. report any weight gain of 2 pounds in 24 hours or 5 pounds in 1 week. no lotions, creams or powders to incisions shower daily, no bathing or swimming. no lifting greater then 10 pounds for 10 weeks from date of surgery. no driving for 1 month and off all narcotics. take all medications as directed followup instructions: please follow-up with dr. in 1 month. ( please follow-up with dr. in weeks. please follow-up with primary care physician weeks. call all providers for appointments. procedure: extracorporeal circulation auxiliary to open heart surgery annuloplasty other and unspecified repair of atrial septal defect open and other replacement of mitral valve with tissue graft diagnoses: mitral valve disorders ostium secundum type atrial septal defect personal history of venous thrombosis and embolism diseases of tricuspid valve chronic passive congestion of liver 

Answer: The patient is high likely exposed to